International Hepatology Communications

Interleukin 2 and / T-cell receptors in peripheral blood of patients with chronic hepatitis C virus infection
pp. 83-93(11)
Authors: Kakumu S.; Ishikawa T.; Okumura A.; Yoshioka K.

Pentoxifylline, but not ursodeoxycholic acid or tauroursodeoxycholic acid inhibits the proliferative effect of sera samples from primary biliary cirrhosis patients
pp. 94-104(11)
Authors: Peterson T.C.; Huet P.-M.

A dose-dependent controlled trial of human lymphoblastoid interferon for genotype 1b chronic hepatitis C associated with high HCV-RNA levels
pp. 105-112(8)
Authors: Komatsu M.; Ishii T.; Ono T.; Kuramitsu T.; Hoshino T.; Masamune O.; Yoshida T.; Yagisawa H.; Yamada N.

Seroepidemiolgy of hepatitis viruses of chronic liver diseases in Bangladesh: high prevalence of HCV among blood donors and healthy person
pp. 113-120(8)
Authors: Akbar S.M.F.; Hossain M.; Hossain F.; Sarker S.; Hossain S.A.S.; Tanimoto K.; Masumoto T.; Michitaka K.; Horiike N.; Onji M.

Retreatment of chronic hepatitis C with ribavirin followed by interferon
pp. 121-129(9)
Authors: Bellobuono A.; Mondazzi L.; Tempini S.; Silini E.; Vicari F.; Asti L.; Zavaglia C.; Ideo G.

Hepatitis G virus/GB virus C infection in an area of high endemic hepatitis C virus infection
pp. 130-135(6)
Authors: Tanaka E.; Nakatsuji Y.; Kobayashi M.; Iijima A.; Ichijo T.; Imai H.; Yoshizawa K.; Sodeyama T.; Kiyosawa K.

Long-term immunosuppression without corticosteroids after orthotopic liver transplantation: A positive therapeutic aim
pp. 136-136(1)
Authors: Fraser G.M.; Grammoustianos K.; Reddy J.; Rolles K.; Davidson B.; Burroughs A.K.

Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation
pp. 136-137(2)
Authors: Plotkin J.S.; Scott V.L.; Pinna A.; Dobsch B.P.; De Wolf A.M.; Kang Y.

Accuracy and significance of pretransplant liver volume measured by magnetic resonance imaging
pp. 137-137(1)
Authors: Caldwell S.H.; De Lange E.E.; Gaffey M.J.; Sue M.; Boyd J.C.; Dickson R.C.; Driscoll C.; Stevenson W.C.; Ishitani M.B.; McCullough C.; Pruett T.L.

Systemic and splanchnic hemodynamic changes in patients with hepatic schistosomiasis
pp. 137-137(1)
Authors: Denie C.; Vachiery F.; Elman A.; Soupison T.; Gadano A.; Moreau R.; Lebrec D.

Significance of extra copies of chromosome 20 and the long arm of chromosome 2 in hepatoblastoma
pp. 137-138(2)
Authors: Swarts S.; Wisecarver J.; Bridge J.A.

Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin
pp. 138-138(1)
Authors: Terrault N.A.; Zhou S.; Combs C.; Hahn J.A.; Lake J.R.; Roberts J.P.; Ascher N.L.; Wright T.L.

Viral dynamics of hepatitis C early after orthotopic liver transplantation: Evidence for rapid turnover of serum virions
pp. 138-138(1)
Authors: Fukumoto T.; Berg T.; Ku Y.; Bechstein W.O.; Knoop M.; Lemmens H.-P.; Lobeck H.; Hopf U.; Neuhaus P.

Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation
pp. 139-139(1)
Authors: McMillan J.S.; Bowden D.S.; Angus P.W.; McCaughan G.W.; Locarnini S.A.

Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: A randomized trial
pp. 139-139(1)
Authors: Sauer P.; Theilmann L.; Herrmann S.; Bruckner T.; Roeren T.; Richter G.; Stremmel W.; Stiehl A.

Kan-1 (bile acid CoA:amino acid N-acyltransferase) messenger RNA as a novel predictive indicator for prognosis of hepatocellular carcinoma patients after partial hepatectomy
pp. 140-140(1)
Authors: Furutani M.; Arii S.; Higashitsuji H.; Mise M.; Niwano M.; Harada T.; Nakayama H.; Fukumoto M.; Imamura M.; Fujita J.

Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure
pp. 140-140(1)
Authors: Ellis A.J.; Hughes R.D.; Wendon J.A.; Dunne J.; Langley P.G.; Kelly J.H.; Gislason G.T.; Sussman N.L.; Williams R.

What constitutes long term survival after surgery for hilar cholangiocarcinoma?
pp. 140-141(2)
Authors: Klempnauer J.; Ridder G.J.; Werner M.; Weimann A.; Pichlmayr R.

Second-look hepatectomy after 5FU arterial infusion in patients with primary unresectable hepatic colorectal metastases: Molecular characteristics of the tumors
pp. 141-141(1)
Authors: Kusunoki M.; Noda M.; Yanagi H.; Kotera H.; Yamamura T.

Acute haemodynamic changes after oral carvedilol, a vasodilating -blocker, in patients with cirrhosis
pp. 141-141(1)
Authors: Forrest E.H.; Bouchier I.A.D.; Hayes P.C.

Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss
pp. 142-142(1)
Authors: Stegall M.D.; Everson G.T.; Schroter G.; Karrer F.; Bilir B.; Sternberg T.; Shrestha R.; Wachs M.; Kam I.

Predictive value of intraoperative biopsies and liver function tests for preservation injury in orthotopic liver transplantation
pp. 142-142(1)
Authors: Gaffey M.J.; Boyd J.C.; Traweek S.T.; Ali M.A.; Rezeig M.; Caldwell S.H.; Iezzoni J.C.; McCullough C.; Stevenson W.C.; Khuroo S.; Nezamuddin N.; Ishitani M.B.; Pruett T.L.

Graft and systemic disease in long-term survivors of liver transplantation
pp. 143-143(1)
Authors: Slapak G.I.; Saxena R.; Portmann B.; Gane E.; Devlin J.; Calne S.R.; Williams R.

Long-term outcome of hepatitis C virus infection after liver transplantation
pp. 143-144(2)
Authors: Boker K.H.W.; Dalley G.; Bahr M.J.; Maschek H.; Tillmann H.L.; Trautwein C.; Oldhaver K.; Bode U.; Pichlmayr R.; Manns M.P.

Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis
pp. 144-144(1)
Authors: Benvegnu L.; Pontisso P.; Cavalletto D.; Noventa F.; Chemello L.; Alberti A.

TIPS and hepatic encephalopathy
pp. 144-145(2)
Author: Pomier-Layrargues G.

Evolution of cardiovascular risk after liver transplantation: A comparison of cyclosporine A and tacrolimus (FK506)
pp. 145-145(1)
Authors: Canzanello V.J.; Schwartz L.; Taler S.J.; Textor S.C.; Wiesner R.H.; Porayko M.K.; Krom R.A.F.

The NIDDK liver transplantation database
pp. 145-146(2)
Authors: Wei Y.L.; Detre K.M.; Everhart J.E.

Immunonephelometric quantification of group-specific component protein in patients with acute liver failure
pp. 146-146(1)
Authors: Wians F.H.; Lin W.; Brown L.P.; Schiodt F.V.; Lee W.M.

Gastric emptying and orocecal transit in portal hypertension and end-stage chronic liver disease
pp. 146-146(1)
Authors: Galati J.S.; Holdeman K.P.; Bottjen P.L.; Quigley E.M.M.

Fulminant hepatitis B virus: Recurrence after liver transplantation in two patients also infected with hepatitis delta virus
pp. 146-147(2)
Authors: Marsman W.A.; Wiesner R.H.; Batis K.P.; Poterucha J.J.; Porayko M.K.; Niesters H.G.M.; Zondervan P.E.; Krom R.A.F.

Liver transplantation in Europe for patients with acute liver failure
pp. 147-147(1)
Authors: Bismuth H.; Samuel D.; Castaing D.; Williams R.; Pereira S.P.